Vitamin D3 K2 MK7: Benefits, Health and Dosage
|
|
Time to read 5 min
|
|
Time to read 5 min
Vitamin D3 and vitamin K2-MK7 form one of the most discussed micronutritional combinations in nutrition. While the biochemical synergy between the two is detailed in our comprehensive guide to vitamin D3 and K2-MK7, this article focuses on a highly practical question: what are the reference serum thresholds, how can dosage be adapted to actual status, and what do leading organizations say about the levels to target?
We review official recommendations, the important nuances that the guidelines themselves add to their own recommendations, and a practical dosage according to profile.
Vitamin D status is measured through serum 25-hydroxyvitamin D (25(OH)D), an intermediate metabolite reflecting total body stores â combined dietary intake and skin synthesis. It is this indicator, rather than a theoretical standard dosage, that should guide supplementation.
Holick et al., in the Endocrine Society's reference guideline, recommend supplementation adapted to age and clinical context for people at risk of deficiency, with serum 25(OH)D testing as the initial diagnostic test for these individuals. An important point, often omitted in popular summaries: the authors explicitly state that there is currently insufficient evidence to recommend systematic screening in people not at risk, or to prescribe vitamin D for the sole purpose of achieving a cardiovascular benefit independent of its role in calcium (Journal of Clinical Endocrinology & Metabolism, DOI). This nuance calls for a more measured interpretation of benefits that are sometimes presented as established.
Martineau et al. conducted an individual participant data meta-analysis combining 25 randomized trials (10 933 participants), showing that vitamin D supplementation reduces the risk of acute respiratory infection by an average of 12% across the entire study population. However, the protective effect was markedly greater among those most deficient at baseline (a 70% reduction in risk among those with an initial level <25 nmol/L) than among people who already had sufficient levels. Furthermore, the protective effect was observed only with regular daily or weekly intake, not with high single doses ("bolus") (BMJ, DOI). It is therefore a real benefit, but one that depends heavily on baseline status and method of administration â not a universal guaranteed effect for everyone.
Available data strongly support the role of vitamin D in bone health and, with important nuances related to baseline status and intake method, in immunity. Non-calcium-related cardiovascular benefits remain insufficiently demonstrated to date according to the reference guidelines themselves â an important point of caution when faced with claims on the subject that can sometimes be overly assertive.
| 25(OH)D status | Interpretation | Generally recommended action |
|---|---|---|
| < 12 ng/mL (30 nmol/L) | Severe deficiency | Medically supervised correction |
| 12â20 ng/mL (30â50 nmol/L) | Deficiency | Correction recommended |
| 20â30 ng/mL (50â75 nmol/L) | Insufficiency | Maintenance supplementation |
| > 30 ng/mL (75 nmol/L) | Sufficiency according to the Endocrine Society | Maintenance, no correction needed |
Holick et al., in the Endocrine Society guideline, establish reference thresholds for vitamin D deficiency and sufficiency and recommend targeted supplementation for people at risk, while highlighting the lack of sufficient evidence for widespread screening or non-calcium-related cardiovascular use (Journal of Clinical Endocrinology & Metabolism, DOI). Martineau et al. confirm a protective effect of vitamin D on respiratory infections, particularly pronounced in deficient individuals and with regular intake rather than bolus dosing (BMJ, DOI). Knapen et al. confirm the relevance of K2-MK7 (180 ”g/day) for bone density in postmenopausal women over 3 years (Osteoporosis International). Geleijnse et al. confirm the association between K2 intake and reduced cardiovascular risk in the Rotterdam cohort (Journal of Nutrition).
D3+K2 formulas dosed according to the ranges studied in clinical trials, for supplementation consistent with the available data.
D3 + K2-MK7 + Zinc-Magnesium: the micronutritional foundation for any athlete looking to support bone health, immunity, and recovery.
To further explore essential micronutrients and their role in athletic performance and health:
Actual vitamin D status, determined through a 25(OH)D blood test, remains the most reliable basis for calibrating supplementation â far more so than a standard dose used without verification. Official recommendations themselves (Endocrine Society) are more cautious than some commercial claims suggest, particularly regarding non-calcium-related cardiovascular benefits, for which evidence remains insufficient to date. The effect on immunity is real but depends on baseline status and intake method (daily rather than bolus).
Combined with K2-MK7 at studied doses (90 to 180 ”g/day), vitamin D3 remains a relevant micronutritional pillar, provided it is used rigorously â prior assessment, appropriate dosage, and ongoing monitoring. This data-based approach, rather than excessive promises, is what Force Addict Pro supports in its selection of health supplements.
Retrouvez les réponses aux questions les plus courantes avant votre achat.
La logique repose sur une complémentarité biochimique. La D3 augmente l'absorption intestinale du calcium ; la K2-MK7 contribue à activer les protéines (ostéocalcine, MGP) qui dirigent ce calcium vers les os plutÎt que vers les tissus mous. Geleijnse et al. (Journal of Nutrition) ont montré qu'un apport élevé en ménaquinone (K2) était associé à un risque réduit de calcification aortique sévÚre dans la cohorte Rotterdam. Cette association répond donc à une logique de cohérence physiologique, plus qu'à une nécessité absolue démontrée par des essais combinant directement les deux molécules.
Les recommandations varient selon le statut individuel, ce qui rend un dosage sanguin préalable particuliÚrement utile. Une insuffisance en vitamine D reste fréquente chez de nombreux sportifs européens, en particulier ceux s'entraßnant en intérieur. Holick et al. (Endocrine Society) recommandent une supplémentation adaptée à l'ùge et au contexte chez les personnes à risque, avec le dosage sanguin comme test diagnostique de référence plutÎt qu'une dose standard appliquée sans vérification.
La MK-7 prĂ©sente une demi-vie nettement plus longue que la MK-4, ce qui permettrait un maintien plus stable des niveaux circulants avec une prise quotidienne unique â c'est l'une des raisons pour lesquelles elle est privilĂ©giĂ©e dans les complĂ©ments destinĂ©s Ă un usage quotidien simple. Les donnĂ©es comparatives directes entre les deux formes sur des critĂšres cliniques (densitĂ© osseuse, santĂ© cardiovasculaire) restent toutefois encore relativement limitĂ©es, la MK-7 Ă©tant la forme la mieux reprĂ©sentĂ©e dans les essais cliniques rĂ©cents comme celui de Knapen et al.
Les rĂ©cepteurs VDR (Vitamin D Receptor) prĂ©sents dans le tissu musculaire suggĂšrent un rĂŽle physiologique plausible. Plusieurs Ă©tudes observationnelles associent un statut en D3 adĂ©quat Ă une meilleure force musculaire, en particulier chez les sujets initialement carencĂ©s â le bĂ©nĂ©fice semble plus marquĂ© lorsque la supplĂ©mentation corrige un dĂ©ficit rĂ©el que chez des sportifs dĂ©jĂ bien pourvus, oĂč l'effet additionnel reste moins certain selon les donnĂ©es disponibles Ă ce jour.
Principalement aux personnes peu exposées au soleil (entraßnement en intérieur, pays nordiques, hiver), aux personnes de plus de 50 ans en lien avec le risque de perte osseuse, et aux personnes ayant un statut carencé confirmé par dosage sanguin. Un dosage préalable de la 25(OH)D reste la démarche la plus rigoureuse pour identifier qui bénéficierait réellement d'une correction, plutÎt qu'une supplémentation généralisée sans vérification individuelle.
C'est difficile pour la D3 et plus difficile encore pour la K2-MK7 spĂ©cifiquement. La D3 se trouve dans les poissons gras, les Ćufs et certains produits enrichis, mais les apports alimentaires courants couvrent rarement les besoins de la majoritĂ© des personnes en automne-hiver. La K2-MK7 est prĂ©sente principalement dans le natto (soja fermentĂ© japonais), aliment peu consommĂ© en Europe ; les fromages et produits laitiers fermentĂ©s apportent surtout d'autres formes de K2 en quantitĂ©s modestes. La supplĂ©mentation reste donc une option pertinente pour atteindre les niveaux Ă©tudiĂ©s dans les essais cliniques.